Article Sidebar
Views pdf: 59
EFFICACY OF ATOSIBAN IN THE TREATMENT OF PRETERM LABOR AT CAN THO OBSTETRICS AND GYNECOLOGY HOSPITAL IN 2023-2025
Main Article Content
Abstract
Background: Preterm birth is one of the leading causes of neonatal mortality; therefore, controlling uterine contractions is crucial. Atosiban, an oxytocin receptor antagonist, effectively inhibits uterine contractions within the first 48 hours, improving outcomes. Objective: To determine the success rate and factors influencing the treatment outcomes of preterm labor using Atosiban at Can Tho Obstetrics and Gynecology hospital. Subjects and Methods: A prospective descriptive study was conducted on 46 pregnant women treated for preterm labor with Atosiban. Results: The rate of labor delay beyond 48 hours was 76.1%. Among them, 39.1% maintained pregnancy for 2–7 days, and 37% for more than 7 days. Treatment outcomes were significantly associated with the frequency and intensity of uterine contractions (p<0.05). Conclusion: Atosiban is an effective method for delaying preterm labor.
Article Details
Keywords
Preterm labor, Atosiban
References
2. Lý Thanh Trường Giang. Nghiên cứu hiệu quả Atosiban trong điều trị dọa sinh non. Tạp chí Phụ Sản. 2016;14(03).
3. Nguyễn Hữu Tiến, Lê Lam Hương. Hiệu quả của Atosiban trong điều trị dọa sinh non từ 28 đến 34 tuần. Tạp chí Phụ Sản. 2017;15(03).
4. Phan Hà Minh Hạnh. Hiệu quả của Atosiban trong trì hoãn chuyển dạ sinh non. Tạp chí Phụ Sản. 2015;14(04).
5. Nguyễn Bích Hồng. Hiệu quả điều trị dọa đẻ non bằng Atosiban tại Bệnh viện Phụ sản Nam Định. Tạp chí Y học Việt Nam. 2023;528(7):1.
6. Cunningham F, Leveno K. Multifetal Pregnancy. Williams Obstetrics 25th ed. McGraw-Hill Education; 2018: 1336-87.
7. Gabbe SG, Niebyl JR. Preterm Labor and Birth. In: Obstetrics: Normal and Problem Pregnancies. 7th ed. Elsevier; 2017.
8. Fuchs F, Senat MV. Multiple gestations and preterm birth. Seminars in Fetal and Neonatal Medicine. 2016;21(2): 113-20. doi:10.1016/j.siny. 2015.12.010.
